1. Home
  2. INCR vs ZTEK Comparison

INCR vs ZTEK Comparison

Compare INCR & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercure Ltd.

INCR

Intercure Ltd.

N/A

Current Price

$0.97

Market Cap

79.3M

Sector

Health Care

ML Signal

N/A

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

N/A

Current Price

$1.00

Market Cap

78.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
INCR
ZTEK
Founded
1994
2008
Country
Israel
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
79.3M
78.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INCR
ZTEK
Price
$0.97
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
190.8K
82.4K
Earning Date
02-15-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$72,158,312.00
$657,134.00
Revenue This Year
$69.54
N/A
Revenue Next Year
$41.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2225.73
52 Week Low
$0.68
$0.62
52 Week High
$1.78
$1.84

Technical Indicators

Market Signals
Indicator
INCR
ZTEK
Relative Strength Index (RSI) 35.54 66.10
Support Level $0.90 $0.64
Resistance Level $1.08 $1.09
Average True Range (ATR) 0.09 0.07
MACD -0.00 0.04
Stochastic Oscillator 55.49 71.11

Price Performance

Historical Comparison
INCR
ZTEK

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: